Clinical subtyping reveals significant differences in calcium-dependent phospholipase A2 activity in schizophrenia. [electronic resource]
Producer: 19991229Description: 401-5 p. digitalISSN:- 0006-3223
- Adult
- Antipsychotic Agents -- therapeutic use
- Arachidonic Acid -- metabolism
- Calcium -- metabolism
- Calmodulin -- metabolism
- Chlorpromazine -- therapeutic use
- Enzyme Activation -- physiology
- Female
- Humans
- Male
- Niacin -- metabolism
- Phospholipases A -- metabolism
- Phospholipases A2
- Schizophrenia -- drug therapy
- Second Messenger Systems -- physiology
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.